tiprankstipranks
CBD Life Sciences (CBDL)
OTHER OTC:CBDL
US Market
Holding CBDL?
Track your performance easily

CBD Life Sciences (CBDL) Income Statement

131 Followers

CBD Life Sciences Income Statement

Last quarter (Q ), CBD Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, CBD Life Sciences's net income was $-21.72K. See CBD Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 14Dec 13Dec 12Dec 11
Total Revenue
$ 122.79K$ 122.79K$ 155.55K$ 0.00$ 0.00
Cost of Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 122.79K$ 122.79K$ 155.55K$ 0.00$ 0.00
Operating Expense
$ 218.46K$ 883.80K$ 499.04K$ 155.72K$ 52.74K
Operating Income
$ -95.67K$ -761.01K$ -343.49K$ -155.72K$ -52.74K
Net Non Operating Interest Income Expense
$ -3.58K$ -15.27K$ -23.50K--
Other Income Expense
-$ -3.86K$ -141.00$ -610.00-
Pretax Income
$ -103.11K$ -780.14K$ -367.13K$ -156.33K$ -52.74K
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -103.11K$ -780.14K$ -367.13K$ -156.33K$ -52.74K
Basic EPS
$ 437.50$ -42.50$ -2.50K$ -2.50K$ -1.25K
Diluted EPS
$ 437.50$ -42.50$ -2.50K$ -2.50K$ -1.25K
Basic Average Shares
$ 12.58K$ 1.82K$ 160.00$ 65.00$ 59.00
Diluted Average Shares
$ 12.58K$ 1.82K$ 160.00$ 65.00$ 59.00
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
$ 24.18K$ 88.33K$ 50.22K$ 10.50K$ 6.00K
Total Expenses
$ 218.46K$ 883.80K$ 499.04K$ 155.72K$ 52.74K
Net Income From Continuing And Discontinued Operation
$ -103.11K$ -780.14K$ -367.13K$ -156.33K$ -52.74K
Normalized Income
$ -103.11K$ -776.28K$ -366.99K$ -155.72K$ -52.74K
Interest Expense
$ 3.58K$ 15.27K$ 23.50K--
EBIT
$ -99.53K$ -764.87K$ -343.63K$ -155.72K$ -52.74K
EBITDA
$ -83.57K$ -741.56K$ -304.97K$ -59.75K$ -52.74K
Currency in USD

CBD Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis